Lancet:插管后导致心包积气积液案例报道

2015-12-03 Mechront译 MedSci原创

2014年6月,37岁男性伴终末期肾病、心包积液,欲控制血压行肾脏切除术,术后4天患者出现呼吸困难进行性加重和端坐呼吸。这9年来每周三次透析治疗。查体:静息时都伴有严重的呼吸困难,P 102次/分,R 20次/分,BP 110/70 mm Hg(波动范围25mm Hg左右)。肺部听诊:左侧基底部闻及支气管呼吸音。辅助检查:胸片:心脏扩大伴气液平。胸部CT:心包积水积液。超声心动图:大量心包积液导致

2014年6月,37岁男性伴终末期肾病、心包积液,欲控制血压行肾脏切除术,术后4天患者出现呼吸困难进行性加重和端坐呼吸。这9年来每周三次透析治疗。

查体:静息时都伴有严重的呼吸困难,P 102次/分,R 20次/分,BP 110/70 mm Hg(波动范围25mm Hg左右)。肺部听诊:左侧基底部闻及支气管呼吸音。

辅助检查:

胸片:心脏扩大伴气液平。
胸部CT:心包积水积液。
超声心动图:大量心包积液导致二尖瓣血流随呼吸变化超过25%,符合心包填塞生理学改变。





医生给患者做了心包积液引流,引出约1L液体。心包积液培养未见明显异常,心包活检提示急、慢性炎症和纤维化。经过引流心包积液治疗后患者病情未再加剧。2周后复查超声心动图示轻微的心包积液。2015年3月患者一般情况良好,仍在血液透析病房。

钝器或穿透性胸部创伤后常伴有心包积气,偶尔可见于(辅助通气)插管后。患者除了最近肾切除术后进行了插管,医生找不到任何其他相关的危险因素。心包积气可以发生在心包积液的基础上,导致具有张力的心包积气积液,就像本例患者一样。影像学资料类似大型的食管裂孔疝或胃扭转,不过心界清晰明确的液气平可以排除这些鉴别诊断。

原始出处:

Ghayumi MA, Fallahi MJ,et al.Tension hydropneumopericardium after routine intubation.Lancet. 2015 Sep 19;386(9999):e13.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=61874, encodeId=2770618e4f4, content=靠谱。,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9801684474, createdName=1de41e0fm11(暂无匿称), createdTime=Thu Jan 28 20:20:00 CST 2016, time=2016-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828333, encodeId=6f77182833341, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Sep 26 23:14:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49088, encodeId=bd84490889a, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:03:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47035, encodeId=ed9e4e0358a, content=需谨慎, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161017/IMG5804CC6615D212822.jpg, createdBy=39cf1666406, createdName=星海孤魂, createdTime=Tue Dec 22 10:41:00 CST 2015, time=2015-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45239, encodeId=c42845239ef, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96091668979, createdName=王斯柯达, createdTime=Tue Dec 08 16:11:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44605, encodeId=b3bc446059f, content=临床注意把, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Thu Dec 03 21:27:00 CST 2015, time=2015-12-03, status=1, ipAttribution=)]
    2016-01-28 1de41e0fm11(暂无匿称)

    靠谱。,,

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=61874, encodeId=2770618e4f4, content=靠谱。,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9801684474, createdName=1de41e0fm11(暂无匿称), createdTime=Thu Jan 28 20:20:00 CST 2016, time=2016-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828333, encodeId=6f77182833341, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Sep 26 23:14:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49088, encodeId=bd84490889a, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:03:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47035, encodeId=ed9e4e0358a, content=需谨慎, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161017/IMG5804CC6615D212822.jpg, createdBy=39cf1666406, createdName=星海孤魂, createdTime=Tue Dec 22 10:41:00 CST 2015, time=2015-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45239, encodeId=c42845239ef, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96091668979, createdName=王斯柯达, createdTime=Tue Dec 08 16:11:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44605, encodeId=b3bc446059f, content=临床注意把, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Thu Dec 03 21:27:00 CST 2015, time=2015-12-03, status=1, ipAttribution=)]
    2016-09-26 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=61874, encodeId=2770618e4f4, content=靠谱。,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9801684474, createdName=1de41e0fm11(暂无匿称), createdTime=Thu Jan 28 20:20:00 CST 2016, time=2016-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828333, encodeId=6f77182833341, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Sep 26 23:14:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49088, encodeId=bd84490889a, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:03:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47035, encodeId=ed9e4e0358a, content=需谨慎, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161017/IMG5804CC6615D212822.jpg, createdBy=39cf1666406, createdName=星海孤魂, createdTime=Tue Dec 22 10:41:00 CST 2015, time=2015-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45239, encodeId=c42845239ef, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96091668979, createdName=王斯柯达, createdTime=Tue Dec 08 16:11:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44605, encodeId=b3bc446059f, content=临床注意把, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Thu Dec 03 21:27:00 CST 2015, time=2015-12-03, status=1, ipAttribution=)]
    2015-12-27 hixiaoluo

    好文章,值得收藏

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=61874, encodeId=2770618e4f4, content=靠谱。,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9801684474, createdName=1de41e0fm11(暂无匿称), createdTime=Thu Jan 28 20:20:00 CST 2016, time=2016-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828333, encodeId=6f77182833341, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Sep 26 23:14:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49088, encodeId=bd84490889a, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:03:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47035, encodeId=ed9e4e0358a, content=需谨慎, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161017/IMG5804CC6615D212822.jpg, createdBy=39cf1666406, createdName=星海孤魂, createdTime=Tue Dec 22 10:41:00 CST 2015, time=2015-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45239, encodeId=c42845239ef, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96091668979, createdName=王斯柯达, createdTime=Tue Dec 08 16:11:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44605, encodeId=b3bc446059f, content=临床注意把, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Thu Dec 03 21:27:00 CST 2015, time=2015-12-03, status=1, ipAttribution=)]
    2015-12-22 星海孤魂

    需谨慎

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=61874, encodeId=2770618e4f4, content=靠谱。,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9801684474, createdName=1de41e0fm11(暂无匿称), createdTime=Thu Jan 28 20:20:00 CST 2016, time=2016-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828333, encodeId=6f77182833341, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Sep 26 23:14:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49088, encodeId=bd84490889a, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:03:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47035, encodeId=ed9e4e0358a, content=需谨慎, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161017/IMG5804CC6615D212822.jpg, createdBy=39cf1666406, createdName=星海孤魂, createdTime=Tue Dec 22 10:41:00 CST 2015, time=2015-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45239, encodeId=c42845239ef, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96091668979, createdName=王斯柯达, createdTime=Tue Dec 08 16:11:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44605, encodeId=b3bc446059f, content=临床注意把, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Thu Dec 03 21:27:00 CST 2015, time=2015-12-03, status=1, ipAttribution=)]
    2015-12-08 王斯柯达

    注意

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=61874, encodeId=2770618e4f4, content=靠谱。,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b9801684474, createdName=1de41e0fm11(暂无匿称), createdTime=Thu Jan 28 20:20:00 CST 2016, time=2016-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828333, encodeId=6f77182833341, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Sep 26 23:14:00 CST 2016, time=2016-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49088, encodeId=bd84490889a, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:03:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47035, encodeId=ed9e4e0358a, content=需谨慎, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161017/IMG5804CC6615D212822.jpg, createdBy=39cf1666406, createdName=星海孤魂, createdTime=Tue Dec 22 10:41:00 CST 2015, time=2015-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45239, encodeId=c42845239ef, content=注意, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96091668979, createdName=王斯柯达, createdTime=Tue Dec 08 16:11:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44605, encodeId=b3bc446059f, content=临床注意把, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Thu Dec 03 21:27:00 CST 2015, time=2015-12-03, status=1, ipAttribution=)]
    2015-12-03 老段

    临床注意把

    0

相关资讯

Heart:秋水仙碱对心脏术后的心包积液没有什么用?

心包积液是心脏术后常见的并发症之一。越来越多的证据表明,秋水仙碱对急性心包炎的治疗可能有效,不过秋水仙碱对减少术后心包积液量的有效性仍未知。因此研究者在法国的10个中心进行了一项随机、双盲、安慰剂对照的试验。该研究纳入了197名心脏术后7-10天、心包填塞高危患者。参与者随机分为秋水仙碱组(1mg/d)和对照组,分别为98人和99人。结局指标为治疗14天后心包积液的改变和迟发性心包填塞发生率。对照

JACC:经皮心包穿刺治疗肺癌患者心包积液,安全且疗效好

心包积液(PE)是癌症患者中常见的症状,但最佳的治疗方法是不明确的。经皮心包穿刺比手术更加微创,但其长期的有效性和安全性还没有得到很好的证明。本研究的目的是评估癌症患者接受经皮心包穿刺治疗PE的结果,并评估血小板减少症患者经改程序治疗的安全性。该研究在2009年11月和2014年10月间招募了MD安德森癌症中心接受经皮心包穿刺治疗PE的所有患者。研究人员分析了与该过程相关的并发症,积液复发率和总生

Chest:肺动脉高压患者出现心包积液预示其死亡风险显著增加

肺动脉高压(PAH)患者心包积液的发生状况及其对患者预后的影响目前仍不清楚。为了加深对这一问题的认识,来自美国明尼苏达州罗切斯特市梅奥诊所心内科的Garvan C. Kane博士及其同事进行了一项研究,研究结果在线发表于2013年8月15日的《CHEST》杂志上。 【原文阅读】 研究结果显示:心包积液在PAH患者中较常见,尽管其很少具有血流动力学意义,但即使是轻度的心包积液也与患者死亡率的显著增

Lancet:常规插管后的张力性水气心包

2014年6月,一个患有晚期肾病和慢性尿毒症心包积液的37岁病人来到我们机构,伴随逐渐恶化的呼吸困难和端坐呼吸,肾切除手术4天后控制高血压。他在拒绝移植肾的前9年每周3次定期进行血液透析。检查静息时病人出现严重呼吸困难,脉搏102次每分钟,呼吸率20次每分钟,血压110/70 mm Hg,伴有25mm Hg诡异变化。肺听诊显示基部支气管呼吸声。胸部X线表明有气-液水平的心脏肥大。胸部CT显示心包积